Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiongbin Lu

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Briefings in Bioinformatics|November 24, 2020
SSMD: a semi-supervised approach for a robust cell type identification and deconvolution of mouse transcriptomics dataXiaoyu Lu, Szu-Wei Tu, Wennan Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2022
Microfluidics guided by deep learning for cancer immunotherapy screeningZheng Ao, Hongwei Cai, Zhuhao Wu, et al.
Cell Cycle (Georgetown, Tex.)|November 19, 2005
53BP1 oligomerization is independent of its methylation by PRMT1Melissa M Adams, Bin Wang, Zhenfang Xia, et al.
Nature Communications|January 13, 2021
Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistanceHai Wang, Yutong Liang, Yue Yin, et al.
ACS Nano|May 26, 2015
Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like CellsWei Rao, Hai Wang, Jianfeng Han, et al.
Nano Today|March 7, 2022
Metformin Bicarbonate-Mediated Efficient RNAi for Precise Targeting of <i>TP53</i> Deficiency in Colon and Rectal CancersJiangsheng Xu, Yunhua Liu, Sheng Liu, et al.
Journal of Neuro-Oncology|October 13, 2007
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1DRobert C Castellino, Massimiliano De Bortoli, Xiongbin Lu, et al.
Cellular Signalling|October 22, 2008
PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activationWenjing Sun, Yang Yu, Gianpietro Dotti, et al.
Nature Nanotechnology|January 19, 2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Science Immunology|August 22, 2025
Reprogramming intratumoral T<sub>reg</sub> cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapyYujing Li, Naresh Singh, Chuanpeng Dong, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Briefings in Bioinformatics|November 24, 2020
SSMD: a semi-supervised approach for a robust cell type identification and deconvolution of mouse transcriptomics dataXiaoyu Lu, Szu-Wei Tu, Wennan Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2022
Microfluidics guided by deep learning for cancer immunotherapy screeningZheng Ao, Hongwei Cai, Zhuhao Wu, et al.
Cell Cycle (Georgetown, Tex.)|November 19, 2005
53BP1 oligomerization is independent of its methylation by PRMT1Melissa M Adams, Bin Wang, Zhenfang Xia, et al.
Nature Communications|January 13, 2021
Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistanceHai Wang, Yutong Liang, Yue Yin, et al.
ACS Nano|May 26, 2015
Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like CellsWei Rao, Hai Wang, Jianfeng Han, et al.
Nano Today|March 7, 2022
Metformin Bicarbonate-Mediated Efficient RNAi for Precise Targeting of <i>TP53</i> Deficiency in Colon and Rectal CancersJiangsheng Xu, Yunhua Liu, Sheng Liu, et al.
Journal of Neuro-Oncology|October 13, 2007
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1DRobert C Castellino, Massimiliano De Bortoli, Xiongbin Lu, et al.
Cellular Signalling|October 22, 2008
PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activationWenjing Sun, Yang Yu, Gianpietro Dotti, et al.
Nature Nanotechnology|January 19, 2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Science Immunology|August 22, 2025
Reprogramming intratumoral T<sub>reg</sub> cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapyYujing Li, Naresh Singh, Chuanpeng Dong, et al.
Pageof 12